Novo Nordisk Invests EUR70 Million to Build Manufacturing Facility in Iran
September 22 2015 - 3:52AM
Dow Jones News
By Dominic Chopping
Danish insulin maker Novo Nordisk A/S (NVO) has signed a
memorandum of understanding with the Food and Drug Administration
of Iran to build a new manufacturing facility in the country.
The EUR70 million plant will manufacture Novo Nordisk's FlexPen
prefilled devices and the project is expected to last five
years.
"It signals our long-term commitment to Iran, a country where
close to 5 million people have diabetes," said Ole Moelskov Bech,
corporate vice president of Novo Nordisk Business Area Near
East.
Construction of the new facility will create 160 jobs, it said.
Novo Nordisk already employs around 130 people in Iran.
-Write to Dominic Chopping at dominic.chopping@wsj.com; Twitter:
@WSJNordics
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
September 22, 2015 04:37 ET (08:37 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2023 to Apr 2024
